What’s The Key To Successful R&D With Artificial Intelligence? ‘Bilingual’ Scientists

Before J&J’s former chief data scientist Najat Khan moved to Recursion, she talked to the Pink Sheet about how AI is transforming trials and driving collaboration between industry and regulators.

Najat Khan
Najat Khan is Recursion’s new chief R&D and chief commercial officer. • Source: Recursion

A tag line on Recursion Pharmaceuticals, Inc.’s website says “welcome to the era of industrialized drug discovery,” and the company’s focus on artificial intelligence tools might make biopharmaceutical researchers worry they could be headed the way of John Henry, the “steel driving” folk hero who is said to have raced against a mechanical drill that was destined to take his job.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from AI

More from Advanced Technologies